Roskamp Institute selected for funding by European Commission for a large-scale clinical trial on Nilvadipine
On May 25, 2011, the Roskamp Institute and an international research consortium led by Trinity College Dublin, were…
On May 25, 2011, the Roskamp Institute and an international research consortium led by Trinity College Dublin, were…
On Dec. 20, 2011, the U.S. Food and Drug Administration (FDA) announced approval of the first and only…
In 2011, the Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from…
On Feb. 19, 2010, the U.S. Food and Drug Administration (FDA) announced it had licensed a quadrivalent meningococcal…
On Dec. 3, 2009, the Thai HIV vaccine clinical trial results were published in the New England Journal…
On Sept. 16, 2009, Brian J. Druker, M.D.,whose research led to the development of Gleevec, the first targeted…
On Sept. 15, 2009, the U.S. Food and Drug Administration (FDA) approved four Influenza A (H1N1) 2009 Monovalent…
Apr. 1, 2008, a team of researchers from Stanford’s School of Medicine announced they had developed a new…
On Sept. 27, 2007, the FDA Amendments Act of 2007 amended the Federal Food, Drug, and Cosmetic Act…
On Jan. 23, 2007, results from a large phase III clinical trial show that adult patients with previously…
In 2007, Dr. Jordan Tang, led a team of scientists at Oklahoma Medical Research Foundation (OMRF) that identified…
On Oct. 5, 2006, the Foundation for the National Institutes of Health, NIH, FDA, and the Pharmaceutical Research…
On May 5, 2006, the Cancer Research Initiative was established in South Carolina, between MUSC, University of South…
On Sept. 16, 2005, preliminary results from a large, clinical trial of digital vs. film mammography showed no…
On Apr. 27, 2005, results from two large NCI-sponsored randomized clinical trials showed that patients with early-stage, HER2-positive,…
On May 27, 2004, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had awarded contracts…
In 2004, the Sarah Cannon Research Institute was formed to bring together community-based physicians, researchers and clinicians to…
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
On Mar. 5, 2003, taking daily aspirin for as little as 3 years was shown to reduce the…
In 2003, China granted the world’s first regulatory approval of a gene therapy product, Gendicine (Shenzhen SiBiono GenTech),…
On Dec. 12, 2002, a National Cancer Institute announced that a clinical trial had shown that reducing the…
In 2002, the Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania…
In 2001, the drug imatinib mesylate (Gleevec) was shown in a clinical trial to be effective against chronic…
On Dec. 16, 2002, researchers at Stanford University Medical Center announced they were continuing a multi-year clinical trial…
In 2001, the Stephenson Cancer Center was established. Located on the University of Oklahoma (OU) Health Sciences Center…
On Jun. 7, 2000, President Clinton issued an Executive Memorandum that directed the Medicare program to revise its…
On Apr. 6, 2000, a $60 million program was announced to address the unequal burden of cancer within…
On Oct. 20, 1997, the Food and Drug Administration (FDA) licensed Purified Chick Embryo Cell (PCEC, RabAvert®) vaccine…
In 1993, Bristol-Myers Squibb launched TAXOL (paclitaxel). The company invested hundreds of millions of dollars to supply TAXOL…
On Sept. 14, 1990, a four-year old girl, Ashanti DeSilva, became the first gene therapy patient. She had…